Authors: RAVINDRA NM ABEDRABBO S GOKCE OH TONG FM PATEL A VELAGAPUDI R WILLIAMSON GD MASZARA WP

Citation: Nm. Ravindra et al., RADIATIVE PROPERTIES OF SIMOX, IEEE transactions on components, packaging, and manufacturing technology. Part A, 21(3), 1998, pp. 441-449

Authors: VILLALONACALERO M EDER J TOPPMEYER D ALLEN L VELAGAPUDI R MYERS M AMATO A KAGENHALLET K RAZVILLAS B OCONNOR L FRAM R KUFE D VONHOFF D ROWINSKY E

Citation: M. Villalonacalero et al., PHASE-I AND PHARMACOKINETIC (PK) STUDY OF LU79553, A NOVEL BIS-NAPHTHALAMIDE ON A DAILY X 5 SCHEDULE, Annals of oncology, 9, 1998, pp. 249-249

Authors: GALLAGHER M ALLEN SL STEVENSON J HILLER K OMARA V VELAGAPUDI R MITCHELL E VILLALONA M VANECHO D JAKIMOWICZ K ALLEN LF FISCHKOFF S ODWYER PJ

Citation: M. Gallagher et al., PHASE-I TRIAL OF THE DOLASTATIN-15 ANALOG LU-103793 (CEMADOTIN) EVERYOTHER DAY FOR 3 DOSES, Annals of oncology, 9, 1998, pp. 386-386

Authors: VILLALONACALERO MA BAKER SD HAMMOND L AYLESWORTH C ECKHARDT SG KRAYNAK M FRAM R FISCHKOFF S VELAGAPUDI R TOPPMEYER D RAZVILLAS B JAKIMOWICZ K VANHOFF DD ROWINSKY E

Citation: Ma. Villalonacalero et al., PHASE-I AND PHARMACOKINETIC STUDY OF THE WATER-SOLUBLE DOLASTATIN-15 ANALOG LU103793 IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES, Journal of clinical oncology, 16(8), 1998, pp. 2770-2779

Authors: JOHNSON F VELAGAPUDI R HORNBERGER W WESTON I LEE J FAULKNER R

Citation: F. Johnson et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF ANCROD GIVEN AS A SINGLE 12-HOUR INFUSION IN HEALTHY, ADULT SUBJECTS, Clinical pharmacology and therapeutics, 63(2), 1998, p.

Authors: KUCHER K MULLERPELTZER H HORNBERGER W MAURER R NOERTERSHEUSER P DUEBBERS K VELAGAPUDI R FAULKNER RD

Citation: K. Kucher et al., DEFIBRINOGENATION EFFECTS OF ANCROD FOLLOWING 3-HOUR INTRAVENOUS-INFUSION DOSES IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 30-30